Analyses of prostaglandin D2 metabolites in urine: Comparison between enzyme immunoassay and negative ion chemical ionisation gas chromatography- mass spectrometry

Prostaglandins and Other Lipid Mediators

Volumn 57, Issue 2-3, 1999, Pages 149-165

  O'Sullivan, S ^a   Mueller, M J ^b   Dahlen S E ^a   Kumlina, M ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

Enzyme immunoassay; Gas chromatography mass spectrometry; Mast cell activation; Prostaglandin D2; Urinary 9 ,11 PGF2

Indexed keywords

ARACHIDONIC ACID; IBUPROFEN; PROSTAGLANDIN D2; PROSTAGLANDIN F2 ALPHA; PROSTAGLANDIN SYNTHASE; PROSTAGLANDIN SYNTHASE INHIBITOR;

ARTICLE; CELL ACTIVATION; CONCENTRATION (PARAMETERS); CROSS REACTION; ENZYME IMMUNOASSAY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; LIPID ANALYSIS; MASS SPECTROMETRY; MAST CELL; NORMAL HUMAN; PROSTAGLANDIN METABOLISM; URINALYSIS; ADULT; ANIMAL; COMPARATIVE STUDY; FEMALE; GUINEA PIG; LIVER MITOCHONDRION; MASS FRAGMENTOGRAPHY; METABOLISM; MIDDLE AGED; URINE;

ADULT; ANIMALS; ARACHIDONIC ACID; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYCLOOXYGENASE INHIBITORS; DINOPROST; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; GUINEA PIGS; HUMANS; IBUPROFEN; IMMUNOENZYME TECHNIQUES; MIDDLE AGED; MITOCHONDRIA, LIVER; PROSTAGLANDIN D2; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES;

EID: 0032588302     PISSN: 00906980     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-6980(98)00076-8     Document Type: Article

References (31)

1. 2 generation after activation of rat and human mast cells with anti-IgE. J Immunol. 129:(4):1982;1627-1631.
2. 4, and prostanoids by human alveolar macrophages analysis by gas chromatography/mass spectrometry . Prostaglandins. 27:(2):1984;163-179.
3. 2 by human platelets. Prostaglandins. 13:(2):1977;225-234.
4. 2 compounds by human eosinophils. A potential mast cell-eosinophil interaction. J Immunol. 141:(7):1988;2413-2419.
5. 2 in patients with systemic mastocytosis. N Engl J Med. 303:(24):1980;1400-1404.
6. 2 into human airways during acute antigen challenge. N Engl J Med. 315:(13):1986;800-804.
7. 4 in bronchoalveolar lavage fluid from atopic asthmatics after endobronchial allergen challenge. Am Rev Respir Dis. 142:(1):1990;112-119.
8. 2 in a normal human male volunteer. J Biol Chem. 260:(24):1985;13172-13180.
9. 2, that inhibits platelet aggregation and constricts blood vessels. J Biol Chem. 260:(27):1985;14621-14625.
10. 2 is a potent contractile agonist of human and guinea pig airways. J Clin Invest. 79:(3):1987;978-983.
11. 2) a unique biologically active prostaglandin produced enzymatically in vivo in humans . Proc Natl Acad Sci USA. 82:(18):1985;6030-6034.
12. 2 in acute and exercise-induced asthma in children. Clin Exp Allergy. 28:(2):1998;181-186.
13. Sladek K., Dworski R., Soja J., Sheller J.R., Nizankowska E., Oates J.A. Eicosanoids in bronchoalveolar lavage fluid of aspirin-intolerant patients with asthma after aspirin challenge. Am J Respir Crit Care Med. 149:(4 Pt 1):1994;940-946.
14. 2 by stable isotope dilution mass spectrometric assay. Methods Enzymol. 187:1990;51-62.
15. 2 after aspirin challenge supports mast cell activation in aspirin-induced airway obstruction. J Allergy Clin Immunol. 98:(2):1996;421-432.
16. O'Sullivan S., Roquet A., Dahlén B., Larsen F., Eklund A., Kumlin M., et al. Evidence for mast cell activation during exercise-induced bronchoconstriction. Eur Respir J. 12:(2):1998;345-350.
17. O'Sullivan S., Roquet A., Dahlén B., Larsson L., Dahlén S.-E., Kumlin M. Urinary excretion of inflammatory mediators during allergen-induced early and late phase asthmatic reactions. Clin Exp Allergy. 28:1998;1332-1339.
18. 2 and its subsequent metabolism in rat, rabbit and guinea pig. Biochemical Pharmacol. 37:(19):1988;3591-3599.
19. Wilgram G., Kennedy E. Intracellular distribution of some enzymes catalyzing reactions in the biosynthesis of complex lipids. J Biol Chem. 238:(8):1963;2615-2619.
20. Hamberg M. Metabolism of prostaglandins in rat liver mitochondria. Eur J Biochem. 6:(1):1968;135-146.
21. Bland J.M., Altman D.G. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1:(8476):1986;307-310.
22. 2-isoprostanes as indicators of non-enzymatic lipid peroxidation in vivo by gas chromatography-mass spectrometry development of a solid-phase extraction procedure . J Chromatogr B Biomed Appl. 667:(2):1995;199-208.
23. 2 in human urine and plasma by gas chromatography-mass spectrometry. J Chromatogr B. 655:(2):1994;173-178.
24. Frolich J.C., Wilson T.W., Sweetman B.J., Smigel M., Nies A.S., Carr K., Watson J.T., Oates J.A. Urinary prostaglandins. Identification and origin. J Clin Invest. 55:1975;763-770.
25. 2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc Natl Acad Sci USA. 87:(23):1990;9383-9387.
26. 2α. J Biol Chem. 270:(17):1995;9800-9808.
27. 2α by human monocytes. Discriminate production by reactive oxygen species and prostaglandin endoperoxide synthase-2. J Biol Chem. 271:(15):1996;8919-8924.
28. 2 in the monkey. J Biol Chem. 254:(10):1979;4152-4163.
29. 2 after inhalation or i.v. infusion in normal men. Biochim Biophys Acta. 963:1988;151-161.
30. 2 by a stable isotope dilution mass spectrometric assay. Anal Biochem. 193:(1):1991;142-148.
31. 2. J Chromatogr. 617:(1):1993;124-128.